RAPT Therapeutics Inc (RAPT) — Dilution Risk Analysis
Current Snapshot
RAPT Therapeutics Inc (RAPT) has a DilutionWatch score of 52/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 52/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
Recent filing forms in the source payload: 4 9, EFFECT 1.
| Form | Filed | Accession |
|---|---|---|
| 4 | 2026-03-05 | 0001643875-26-000006 |
| 4 | 2026-03-05 | 0001782274-26-000003 |
| 4 | 2026-03-05 | 0001646110-26-000001 |
| 4 | 2026-03-05 | 0001635616-26-000001 |
| 4 | 2026-03-05 | 0001337831-26-000001 |
| 4 | 2026-03-05 | 0001270774-26-000003 |
| 4 | 2026-03-05 | 0001733915-26-000003 |
| 4 | 2026-03-05 | 0001261974-26-000003 |
| 4 | 2026-03-05 | 0001693564-26-000003 |
| EFFECT | 2026-03-04 | 9999999995-26-000717 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Cash runway | 16 months | Source |
| Three-year share count growth | 544.51% | Source |
DilutionWatch Analysis
- Risk Level
- HIGH (Score: 52/10) Source
- Cash Runway
- 16 months Source
- Share Count Growth (3-Year)
- 544.51% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.